Surgery Partners Price to Free Cash Flow Ratio 2013-2025 | SGRY
Historical price to free cash flow ratio values for Surgery Partners (SGRY) since 2013.
| Surgery Partners Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2026-01-21 | 15.47 | 8.24 | |
| 2025-09-30 | 21.64 | $1.88 | 11.52 |
| 2025-06-30 | 22.23 | $1.73 | 12.82 |
| 2025-03-31 | 23.75 | $1.42 | 16.71 |
| 2024-12-31 | 21.17 | $1.68 | 12.58 |
| 2024-09-30 | 32.24 | $1.31 | 24.61 |
| 2024-06-30 | 23.79 | $1.64 | 14.48 |
| 2024-03-31 | 29.83 | $1.54 | 19.36 |
| 2023-12-31 | 31.99 | $1.84 | 17.41 |
| 2023-09-30 | 29.25 | $1.43 | 20.43 |
| 2023-06-30 | 44.99 | $0.88 | 51.03 |
| 2023-03-31 | 34.47 | $0.77 | 44.59 |
| 2022-12-31 | 27.86 | $0.99 | 28.12 |
| 2022-09-30 | 23.40 | $1.22 | 19.23 |
| 2022-06-30 | 28.92 | $1.01 | 28.50 |
| 2022-03-31 | 55.05 | $0.48 | 115.00 |
| 2021-12-31 | 53.41 | $0.49 | 108.98 |
| 2021-09-30 | 42.34 | $0.42 | 100.67 |
| 2021-06-30 | 66.62 | $1.66 | 40.03 |
| 2021-03-31 | 44.26 | $5.52 | 8.01 |
| 2020-12-31 | 29.01 | $5.38 | 5.39 |
| 2020-09-30 | 21.90 | $5.33 | 4.11 |
| 2020-06-30 | 11.57 | $4.95 | 2.34 |
| 2020-03-31 | 6.53 | $1.87 | 3.49 |
| 2019-12-31 | 15.66 | $1.52 | 10.28 |
| 2019-09-30 | 7.39 | $2.18 | 3.39 |
| 2019-06-30 | 8.14 | $1.93 | 4.21 |
| 2019-03-31 | 11.28 | $2.37 | 4.76 |
| 2018-12-31 | 9.79 | $2.58 | 3.79 |
| 2018-09-30 | 16.50 | $2.82 | 5.84 |
| 2018-06-30 | 14.90 | $2.36 | 6.31 |
| 2018-03-31 | 17.15 | $1.71 | 10.02 |
| 2017-12-31 | 12.10 | $1.89 | 6.40 |
| 2017-09-30 | 10.35 | $1.39 | 7.42 |
| 2017-06-30 | 22.75 | $1.53 | 14.86 |
| 2017-03-31 | 19.50 | $2.10 | 9.28 |
| 2016-12-31 | 15.85 | $1.79 | 8.87 |
| 2016-09-30 | 20.24 | $2.71 | 7.48 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $2.022B | $3.114B |
| Surgery Partners, Inc. is a healthcare services company. The Company's outpatient delivery model focused on providing solutions for surgical and related ancillary care in support of its patients and physicians. Its operating segment consists of Surgical Facility Services segment, Ancillary Services segment and Optical Services segment. Surgery Partners, Inc. is based in Nashville, Tennessee. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $165.519B | 30.39 |
| HCA Healthcare (HCA) | United States | $105.969B | 17.54 |
| CVS Health (CVS) | United States | $101.669B | 11.69 |
| Elevance Health (ELV) | United States | $81.575B | 11.96 |
| Cencora (COR) | United States | $68.028B | 21.93 |
| Natera (NTRA) | United States | $32.485B | 0.00 |
| DiDi Global (DIDIY) | China | $22.874B | 21.13 |
| Labcorp Holdings (LH) | United States | $22.492B | 17.15 |
| Medpace Holdings (MEDP) | United States | $16.969B | 42.13 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.166B | 0.00 |
| Viatris (VTRS) | United States | $14.581B | 5.43 |
| BioMerieux (BMXMF) | France | $14.360B | 0.00 |
| ICON (ICLR) | Ireland | $14.259B | 14.15 |
| Solventum (SOLV) | United States | $13.695B | 13.29 |
| Revvity (RVTY) | United States | $12.686B | 23.36 |
| CochLear (CHEOY) | Australia | $11.814B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.738B | 20.68 |
| Avantor (AVTR) | United States | $8.080B | 12.34 |
| Sonic Healthcare (SKHHY) | Australia | $7.695B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.412B | 0.00 |
| HealthEquity (HQY) | United States | $7.177B | 26.84 |
| BrightSpring Health Services (BTSG) | United States | $6.985B | 41.65 |
| Bausch + Lomb (BLCO) | Canada | $6.053B | 39.74 |
| PACS (PACS) | United States | $5.590B | 33.99 |
| Sotera Health (SHC) | United States | $5.310B | 25.60 |
| Alignment Healthcare (ALHC) | United States | $4.550B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $2.881B | 50.60 |
| Concentras Parent (CON) | United States | $2.808B | 17.53 |
| Organon (OGN) | United States | $2.459B | 2.59 |
| Progyny (PGNY) | United States | $2.188B | 43.02 |
| Establishment Labs Holdings (ESTA) | United States | $1.878B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.866B | 11.14 |
| Ardent Health (ARDT) | United States | $1.188B | 3.88 |
| Nutex Health (NUTX) | United States | $1.087B | 8.32 |
| Teladoc Health (TDOC) | United States | $1.077B | 0.00 |
| CareDx (CDNA) | United States | $1.039B | 16.98 |
| Omada Health (OMDA) | United States | $0.911B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.883B | 14.44 |
| InnovAge Holding (INNV) | United States | $0.806B | 0.00 |
| Embecta (EMBC) | United States | $0.728B | 4.14 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.702B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.590B | 0.00 |
| CryoPort (CYRX) | United States | $0.538B | 0.00 |
| Enhabit (EHAB) | United States | $0.528B | 23.70 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.496B | 0.00 |
| SBC Medicals (SBC) | United States | $0.440B | 8.09 |
| Agilon Health (AGL) | United States | $0.405B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.343B | 5.51 |
| Oncology Institute (TOI) | United States | $0.338B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.302B | 63.60 |
| Shoulder Innovations (SI) | United States | $0.290B | 0.00 |
| So-Young (SY) | China | $0.270B | 0.00 |
| KindlyMD (NAKA) | United States | $0.185B | 0.00 |
| Beauty Health (SKIN) | United States | $0.184B | 0.00 |
| LifeMD (LFMD) | United States | $0.171B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.134B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.125B | 0.00 |
| DocGo (DCGO) | United States | $0.079B | 0.00 |
| Biodesix (BDSX) | United States | $0.071B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.064B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.045B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.044B | 0.00 |
| Pomdoctor - (POM) | China | $0.030B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.24 |
| OSR Holdings (OSRH) | United States | $0.018B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.017B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.014B | 0.00 |
| Lifeward (LFWD) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| INVO Fertility (IVF) | United States | $0.006B | 0.00 |
| Pheton Holdings (ITOC) | China | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |